Cannabis Access Regulations Study (CANARY)

The CANARY study is a patient-centered assessment of the impact of the regulatory changes regarding access to cannabis for medical purposes in Canada. The study is the first to offer patients? perspectives regarding their experience of access to medical cannabis after the implementation of the new federal regulations that have created a decentralized competitive national […]

Read More
Sleep quality and weaning from mechanical ventilation: a physiological clinical study

In mechanically ventilated critically ill patients, sleep disruption may contribute to prolonged weaning leading to longer intensive care unit stay and hospital mortality. It was reported that sleep disruption affects the outcome of noninvasive ventilation and we hypothesize that it may also have an impact in mechanically ventilated patients on the weaning outcome. We propose […]

Read More
Development of Monoclonal Antibodies and Rapid Lateral Flow Test Kit for the Specific Detection of Streptococcus agalactiae

Streptococcus agalactiae (S. agalactiae) is a worldwide-distributed bacterium. It is a major infectious agent to humans, cattle and aquatic animals. The outbreak and prevalence of S. agalactiae in aquaculture has been reported in different countries as one of the major causes of mortality leading to serious economic losses and threatening the sound development of aquaculture. […]

Read More
Characterization of infarct-sparing mechanisms of Celastrol and related compounds

The ability to repair or regenerate damaged heart presents a major challenge in the treatment of cardiovascular diseases. Current treatments are unsuccessful to regenerate dead myocardium and fail to address the challenge caused by the early loss of cardiac cells. The use of a new drug to stimulate protection of the heart during an ongoing […]

Read More
Site-specific Immunomodulators for COPD

Qu Biologics is a clinical-stage biopharmaceutical company developing and evaluating an innovative immunotherapeutic approach to treating disease rooted in immune pathology/dysfunction. Qu’s proprietary technology platform, site-specific immunomodulators (SSI), act to stimulate the body’s own immune system to reverse the chronic inflammation underlying many conditions including cancer and immune-mediated diseases. For lung diseases, Qu’s platform SSI, […]

Read More
Broadband Internet Policy and Farmers’ Collective Agency in Vietnam

Vietnam approved the national rural information and communication plan in 2011 that includes the building of a 420 million CAD broadband network infrastructure intended to link all smallest administrative units by 2015. However, the country has not achieved this goal yet. Vietnam has experienced countless failures in rolling out Information Communication Technology systems mainly because […]

Read More
A new paradigm for the discovery of anti-cancer drugs based on tumour RNA disruption

While chemotherapy drugs are effective in combating tumour growth in cancer patients, many such drugs permit the development of drug-resistant tumours and progression of the disease. We have observed that several chemotherapy agents induce the degradation of tumour cell ribonucleic acid (RNA) in the laboratory and in cancer patients. We have further shown that this […]

Read More
Dopamine Receptor Imaging in Dementia Using Hybrid PET/MRI

Although life expectancy is increasingly associated with the treatment of heart disease and cancer, there has been virtually no improvement in life expectancy for patients with dementia. Dementia has a devastating impact to the patient, family members and society because patients become dependent on family caregivers, who are then less productive in other aspects of […]

Read More